[1]XUAN D,WEN W,TIAN S,et al.Prognostic value of maximum standard uptake value,metabolic tumor volume,and total lesion glycolysis of 18F-FDG PET/CT in patients with renal carcinoma:A protocol for systematic review and Meta analysis[J].Medicine,2020,99(20):e19988.
[2]LUCCA I,KLATTE T,FAJKOVIC H,et al.Gender differences in incidence and outcomes of urothelial and kidney cancer[J].Nat Rev Urol,2015,12(12):653-653.
[3]张冰玉,邓显忠,朱平宇.肥胖与肾癌相关性研究进展[J].现代泌尿外科杂志,2017,22(12):962-966.
ZHANG BY,DENG XZ,ZHU PY.Research progress on the relationship between obesity and renal cell carcinoma [J].Journal of Modern Urology,2017,22(12):962-966.
[4]VITALE MG,CARTENI GIACOMO.Recent developments in second and third line therapy of metastatic renal cell carcinoma [J].Expert Rev Anticancer Ther,2016,16(5):469-471.
[5]SANCHEZ-GASTALDO A,KEMPF E,GONZALEZ DEL ALBA A,et al.Systemic treatment of renal cell cancer:a comprehensive review[J].Cancer Treat Rev,2017,60:77-89.
[6]CAVALIERE C,D'ANIELLO C,PEPA CD,et al.Current and emerging treatments for metastatic renal cell carcinoma[J].Curr Cancer Drug Targets,2018,18(5):468-479.
[7]MIAO D,MARGOLIS CA,GAO W,et al.Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma[J].Science,2018,359(6377):801-806.
[8]周映伽,沈红梅,黄杰.表皮生长因子与恶性肿瘤相关性的研究进展[J].肿瘤基础与临床,2014,27(05):452-455.
ZHOU YJ,SHEN HM,HUANG J.Advances in the study of the relationship between pro-epidermal growth factor and malignant tumors [J].Basic and Clinical Oncology,2014,27(05):452-455.
[9]MULLHAUPT B,FEREN A,JONES A,et al.DNA sequence and functional characterization of the human and rat epidermal growth factor promoter:regulation by cell growth[J].Gene,2000,250(1):191-200.
[10]ZHU X,SHEN Y,XIE Q.The association between EGF A61G polymorphism and risk of colorectal cancer in a Chinese population:a case-control study[J].Biosci Rep,2019,39(5):BSR20190495.
[11]董伟,吴娟,王瑞平,等.胃癌病理组织类型、表皮生长因子单核苷酸多态性与胃癌患者舌苔形成的相关性[J].中华中医药杂志,2019,34(09):4259-4262.
DONG W,WU J,WANG RP,et al.Correlation of pathologic tissue type,pro-epidermal growth factor single-nucleotide polymorphism and tongue coating in patients with gastric cancer[J].Chinese Journal of Traditional Chinese Medicine,2019,34(09):4259-4262.
[12]薛艺萌,李靖若,孔攀,等.三阴性乳腺癌组织乳腺癌易感基因1与表皮生长因子受体的表达及临床意义[J].河南外科学杂志,2019,25(03):42-44.
XUE YM,LI JR,KONG P,et al.Expression and clinical significance of breast cancer susceptibility gene 1 and EGFR in triple negative breast cancer[J].Henan Journal of Surgery,2019,25(03):42-44.
[13]王纪传,戴英增,王婷婷.表皮生长因子、雄激素受体和表皮生长因子受体在肝癌组织中的表达及影响因素分析[J].癌症进展,2020,18(05):505-508.
WANG JC,DAI YZ,WANG TT.Expression of epidermal growth factor,androgen receptor and epidermal growth factor receptor in liver cancer and analysis of influencing factors[J].Cancer Progression,202,18(05):505-508.
[14]PETEJOVA N,MARTINEK A.Renal cell carcinoma:Review of etiology,pathophysiology and risk factors [J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2016,160(2):183-194.
[15]LEE JE,SPIEGELMAN D,HUNTER DJ,et al.Fat,protein,and meat consumption and renal cell cancer risk:a pooled analysis of 13 prospective studies [J].J Nati Cancer Inst,2008,100(23):1695-1706.
[16]CACINA C,ARIKAN S,DZKYL Y,et al.Analyses of EGF A61G gene variation and serum EGF level on gastric cancer susceptibility and clinicopathological parameters[J].Anticancer Res,2015,35(5):2709-2713.
[17]NAKAMURA TM,MORIN GB,CHAPMAN KB,et al.Telomerase catalytic subunit homologs from fission yeast and human [J].Science,1997,277(5328):955-959.
[18]LIN L,LI G,ZHANG Z,et al.Association of epidermal growth factor +61 A/G polymorphism in Chinese patients with colon cancer[J].Genet Test and Mol Biomarkers,2012,16(9):1142-1145.
[19]WANG Y,TIAN T,HU Z,et al.EGF promoter SNPs,plasma EGF levels and risk of breast cancer in Chinese women[J].Breast Cancer Res Treat,2008,111(2):321-327.
[20]邢兆辉,徐洋,李红松,等.MLH1、MSH2基因多态性与肾癌发病风险的相关性研究[J].黑龙江医学,2018,42(11):1152-1154.
XING ZH,XU Y,LI HS,et al.Relationship between MLH1,MSH2 polymorphism and risk of renal cell carcinoma[J].Heilongjiang Medicine,2018,42(11):1152-1154.
[21]ZHU J,MENG X,YAN F,et al.A functional epidermal growth factor (EGF) polymorphism,EGF serum levels and renal cell carcinoma risk in a Chinese population [J].J Hum Genet,2010,55(4):236-240.
[22]袁军,殷长军,赵虎,等.肾透明细胞癌易感性与表皮生长因子基因-61G>A多态性的相关性[J].中华实验外科杂志,2011,28(1):108-111.
YUAN J,YIN CJ,ZHAO H,et al.Association between the susceptibility to renal clear cell carcinoma and the polymorphism of pro-epidermal growth factor-61G>A[J].Chinese Journal of Experimental Surgery,2011,28(1):108-111.